Precision Pharmacotherapy Smoking Cessation Program

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to determine the benefits of a personalized treatment approach, compared to a non-personalized treatment approach, for smoking cessation. In other words, this study will help us know if recommending a specific medication to individual smokers will make it easier to quit smoking than simply offering an option of medications. The specific recommendation for a medication will be based on a test that measures how quickly a smoker breaks down, or metabolizes, nicotine.
Epistemonikos ID: 0e919c1ae5422bd84c4f35bf0f4fa4cbf1d7e4ab
First added on: May 08, 2024